Navigation Links
BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device
Date:6/17/2009

LAVAL, QC, June 17 /PRNewswire-FirstCall/ - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced statistically significant results from an analysis of patients who completed their 12 month follow-up in the BST-CarGel(R) randomized clinical trial. Specifically, statistically significant evidence of improved repair tissue quality due to BST-CarGel treatment was found during analyses of tissues biopsied from the knees of 22 patients. The ongoing multicenter pivotal trial is evaluating the ability of BST-CarGel to repair cartilage lesions in the knee when applied to a microfractured lesion compared to microfracture alone (control) in 80 patients. Final results on all 80 patients are expected in the first half of 2010.

"We are excited by these positive results, which will be highly supportive in our ongoing discussions with potential orthopedic partners. Although we have not yet completed all facets of this Interim Analysis, we felt obligated to disclose these first histology results as biopsy data is considered the gold standard for assessment of cartilage repair," said Mr. Michel Lagueux, Chairman of the Board.

Using histological methods (i.e. analyses by microscope) to process and analyze the biopsied tissues from 13 BST-CarGel patients and 9 microfracture patients, and using third parties to perform the statistical analysis, statistically significant improvements were identified for critical tissue characteristics following BST-CarGel treatment compared to microfracture alone. In particular, after applying the International Cartilage Repair Society's (ICRS) histological scoring systems I and II to the biopsies in a blinded manner, several parameters were found to be statistically significant between treatment groups at p(less than)0.05. First, the Overall ICRS II score was significantly better for the BST-CarGel group than for the microfracture group (p=0.045), with
'/>"/>

SOURCE BioSyntech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
2. BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009
3. Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients
4. Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
5. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
6. Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
7. PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice
8. Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors
9. Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
10. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
11. Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... , ... uBiome, the leading microbial genomics company, is offering talented researchers with ... 16S laboratory analysis. The goal is to fast-track a study with the greatest potential ... own dashboard, enabling them to view and compare the results of their study, as ...
(Date:7/7/2015)... DE (PRWEB) , ... July 07, 2015 , ... ... that work together to lower barriers to innovation in life science R&D, has ... in the last quarter include another top ten pharmaceutical company joining as a ...
(Date:7/6/2015)... 2015  Emdeon Inc. today announced that ... to acquire Altegra Health, a national provider ... data aggregation and analytics with unique member ... insights and improved management for value-based healthcare.  ... adjustment and quality analytics and Emdeon,s Intelligent ...
(Date:7/6/2015)... , July 6, 2015 ImmunoCellular Therapeutics, Ltd. ... an agreement with Novella Clinical (Novella), to ... patients with newly diagnosed glioblastoma. Novella is a full-service, ... to small to mid-sized oncology companies. The ICT-107 phase ... the US, Europe and ...
Breaking Biology Technology:uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 3Pistoia Alliance Continues to Attract New Members 2Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2
... ORLANDO, Fla., Sept. 20 HelixLife™ recently launched ... DNA Products (Vitamins & Skin Serum), Anti-Acne Skin ... These product lines were developed in partnership with ... solutions to personal health and skin care using ...
... Amex: NBS ) ("NeoStem" or the "Company"), an ... announced today that its CEO, Dr. Robin Smith, is appearing ... FOX Business Network.   The show,s first segment ... air each upcoming Saturday at 1:30 p.m. Eastern Time through ...
... Agreement With L-1 Identity Solutions for the Purchase... -- PARIS, September 20, 2010 ... ... --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Biology Technology:HelixLife Launches Custom Health Supplements, Anti-Aging and Acne Skin Serums 2FOX Business Network Airing In-Depth Look at NeoStem 2FOX Business Network Airing In-Depth Look at NeoStem 3Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 2Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 3Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 4Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 5Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 6Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 7Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 8Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 9Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 10Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 11Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses 12
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 ... Produktlinie mit DNA-Tests verbessert den Analyseprozess und senkt Laborkosten ... Frankfurt Prime Standard: QIA) hat heute in den ... Investigator ® für die forensische ... Kits zur Erstellung genetischer Fingerabdrücke bieten eine integrierte Lösung ...
(Date:6/16/2015)... , June 16, 2015  With the increasing ... security remains a top concern. The recent compromise of ... the need for strong authentication within government agencies. ... a biometric one-time password (OTP) authenticator, has been submitted ... (FIPS) 140-2 Level 3 validation for tamper proofing. ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... recently sent to President Obama, more than 200 organizations, ... lauded the President for his outstanding leadership in advancing ... the letter below. Dear Mr. President: ... higher education communities, we wish to commend you and ...
... and limited water availability are major stresses for plants ... Ben-Gurion University of the Negev has announced the ... a subsidiary of Bayer CropScience based in Ghent, Belgium, ... builds upon the expertise and breakthrough results from Dr. ...
... is certainly not free of risk. Since 2005, the ... and Gttingen have registered a total of 17 patients ... pharmacologist Dieter Mller and his coauthors describe the documented ... Deutsches rzteblatt International (Dtsch Arztebl Int 2009; 106(13): ...
Cached Biology News:Business, scientific, higher education groups laud President Obama's commitment to science 2Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience 2
Salmonella typhimurium Immunogen: Heat inactivated bacterial cells of Salmonella typhimurium B Storage: 4 C...
... High Performance, 5 ml. The same ... HiTrap Streptavidin columns for fast, reliable ... into Tricorn 5/50 GL, XK 16/20, ... purifications are required.Extremely useful for exploiting ...
... Immunogen: Synthetic peptide derived ... human SENP1. Specificity: Specific ... SENP1. Reactivity: Human (positive ... Hep2 cell lysates HL-60 cell ...
...
Biology Products: